GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,557,000 | -61.9% | 22,160 | -67.9% | 0.07% | -70.5% |
| Q3 2020 | $6,715,000 | -11.8% | 68,980 | +11.2% | 0.25% | -25.1% |
| Q2 2020 | $7,611,000 | +61.8% | 62,020 | +15.4% | 0.34% | +22.3% |
| Q1 2020 | $4,705,000 | -28.5% | 53,730 | -14.6% | 0.27% | +3.4% |
| Q4 2019 | $6,578,000 | -3.2% | 62,910 | +6.5% | 0.26% | -14.8% |
| Q3 2019 | $6,793,000 | -28.4% | 59,050 | +7.2% | 0.31% | -26.1% |
| Q2 2019 | $9,492,000 | +51.2% | 55,060 | +47.8% | 0.42% | +52.5% |
| Q1 2019 | $6,279,000 | +108.2% | 37,250 | +20.3% | 0.28% | +76.9% |
| Q4 2018 | $3,016,000 | -49.4% | 30,970 | -10.2% | 0.16% | -39.3% |
| Q3 2018 | $5,958,000 | +84.3% | 34,490 | +48.9% | 0.26% | +87.6% |
| Q2 2018 | $3,233,000 | – | 23,170 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |